Animal Antibiotics and Antimicrobials Market Projected To Surpass $8 Billion By 2030 At 7.3% CAGR
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Animal Antibiotics and Antimicrobials Market Become By 2030 Compared To 2026?
The animal antibiotics and antimicrobials market has shown substantial expansion in recent years. It is predicted to climb from $5.64 billion in 2025 to $6.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. The increase observed historically can be attributed to factors such as a growing livestock population, a heightened occurrence of animal infectious diseases, the development of commercial animal farming, an improving veterinary healthcare infrastructure, and the past practice of using antibiotics for growth promotion.
The animal antibiotics and antimicrobials market size is predicted to undergo significant expansion in the upcoming years, with its value set to reach $8.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This expansion is primarily fueled by more rigorous regulations addressing antimicrobial resistance, an increasing demand for secure animal-derived food products, a rise in the number of companion animal owners, enhanced investment in veterinary drug research and development, and the wider adoption of preventive animal healthcare practices. Notable trends anticipated during this period include the implementation of precision veterinary medicine, sustainable livestock health management strategies, digital monitoring of antimicrobial usage, AI-driven drug discovery for veterinary antibiotics, and the intelligent manufacturing of veterinary pharmaceuticals.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6712&type=smp
Which Core Factors Are Supporting The Expansion Of The Animal Antibiotics and Antimicrobials Market?
Rising demand for animal-derived food products is driving the growth of the animal antibiotics and antimicrobials market. Animal-derived food products such as milk, eggs, meat, and others act a major source of nutrition and plays a prominent role in human diet. The companies/institutions involved in production of animal-derived foods are focusing on developing healthy herd or disease-free herd through utilization of animal antibiotics and antimicrobials on precautionary basis. For instance, in June 2023, according to a report published by the Food and Agriculture Organization (FAO), an Italy-based specialized agency of the United Nations, global meat production is projected to increase modestly by 0.8 percent in 2023, reaching 365 million tonnes (carcass weight equivalent) compared to 2022. Therefore, increasing demand for animal-derived food products is expected to boost demand for animal antibiotics and antimicrobials during forecast period.
How Is The Animal Antibiotics and Antimicrobials Market Structured Across Different Market Segments?
The animal antibiotics and antimicrobials market covered in this report is segmented –
1) By Type Of Product: Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Type Of Products
2) By Mode Of Delivery: Premixes, Oral Powder, Oral Solution, Injection, Other Modes Of Delivery
3) By Animal Type: Food-Producing Animals, Companion Animals
Subsegments:
1) By Tetracyclines: Oxytetracycline, Chlortetracycline, Doxycycline
2) By Penicillin: Penicillin G, Ampicillin, Amoxicillin
3) By Sulfonamides: Sulfadimidine, Sulfadiazine, Sulfamethoxazole
4) By Macrolides: Erythromycin, Tylosin, Tulathromycin
5) By Aminoglycosides: Gentamicin, Neomycin, Streptomycin
6) By Lincosamides: Lincomycin, Clindamycin
7) By Fluoroquinolones: Enrofloxacin, Marbofloxacin, Ciprofloxacin
8) By Cephalosporins: Cefquinome, Cephalexin, Cefoperazone
9) By Other Type Of Products: Nitrofurans, Phenicols
What Trends Are Affecting The Animal Antibiotics and Antimicrobials Market Dynamics?
Major companies operating in the animal antibiotics and antimicrobials market are focusing on developing innovative solutions, such as novel injectable multi-species treatments, to enhance therapeutic efficacy, improve ease of administration across different livestock species, and address the growing demand for effective disease management solutions amid rising concerns over animal health, productivity, and antimicrobial resistance. A novel injectable multi-species treatment refers to a newly developed (innovative) injectable medication that is designed to be safely and effectively used across multiple animal species, such as cattle, swine, sheep, or goats, rather than being limited to a single species. For instance, in February 2025, Elanco Animal Health Incorporated, a US-based animal health company, launched Pradalex (pradofloxacin injection), an innovative antibiotic specifically indicated for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD), marking the first new molecule and injectable antibiotic for these indications approved by the U.S. FDA in roughly two decades. Pradalex’s novel mode of action enables comprehensive coverage against major BRD and SRD bacteria, delivers high therapeutic concentrations rapidly post-injection, and features an industry-leading withdrawal period, enhancing both efficacy and producer convenience while fitting into integrated disease management programs on farms. This launch underscores how market players are advancing antimicrobial therapies to address significant livestock health challenges, improve animal welfare, and support sustainable production systems.
Who Are The Companies Shaping The Animal Antibiotics and Antimicrobials Market Landscape?
North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Animal Antibiotics and Antimicrobials Market Report:
Which Area Represents The Largest Portion Of The Animal Antibiotics and Antimicrobials Market?
North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Animal Antibiotics and Antimicrobials Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=6712&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model